Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenocortical Carcinoma × Sorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 62 Carcinoma, Renal Cell 35 Liver Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Breast Neoplasms 14 Neoplasms 13 Neoplasm Metastasis 13 Melanoma 12 Leukemia, Myeloid, Acute 10 Sarcoma 9 Thyroid Neoplasms 8 Lung Neoplasms 8 Kidney Neoplasms 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Glioblastoma 4 Carcinoma, Medullary 4 Breast Neoplasms, Male 4 Brain Neoplasms 4 Thyroid Diseases 3 Thyroid Carcinoma, Anaplastic 3 Stomach Neoplasms 3 Recurrence 3 Osteosarcoma 3 Myelodysplastic Syndromes 3 Leiomyosarcoma 3 Hemangiosarcoma 3

Interventions

pembrolizumab 5 Mitotane 5 Cisplatin 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 sodium thiosulfate 2 relacorilant 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 lenvatinib 1 gossypol acetic acid 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Suramin 1 Sorafenib 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Oxaliplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786110 2009-02-24

PAXO

University of Turin, Italy

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡